Skip to Content

I111 (Minocycline Extended Release 135 mg)

Pill imprint I111 has been identified as Minocycline hydrochloride extended release 135 mg.

Minocycline is used in the treatment of acne; bacterial infection; rosacea; rheumatoid arthritis; skin or soft tissue infection (and more), and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substance Act (CSA).

Minocycline hydrochloride extended release 135 mg I111
Discount Card Promo
Minocycline hydrochloride extended release
Imprint:
I111
Strength:
135 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Tetracyclines
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5387
Inactive Ingredients:
silicon dioxide colloidal
lactose monohydrate
magnesium stearate
titanium dioxide
triacetin
ferric oxide yellow
hypromellose 2208 (15000 mPa.s)
hypromellose 2910 (15 mPa.s)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide